Hovid Pharmacy Sdn. Bhd. (Malaysia)

Hovid Pharmacy Sdn. Bhd. is a Malaysia-based healthcare and pharmaceutical company operating within the broader Hovid group ecosystem, supporting the commercialization and distribution of pharmaceutical and consumer healthcare offerings. The company's business activities align with the group's branded generics and consumer health strategy, encompassing the sale and distribution of a broad portfolio that includes generic prescription medicines, over-the-counter (OTC) products, health supplements, disinfectant and hygiene solutions, medical devices, and selected consumer products. Within the Hovid platform, product breadth is a key feature, with a portfolio spanning hundreds of SKUs addressing common therapeutic and wellness needs, and supported by in-house capabilities across research and development, quality assurance, and manufacturing. Key brands associated with the wider group include long-standing household names such as Ho Yan Hor herbal tea and the Tocovid tocotrienol-based supplement line, reflecting a dual focus on traditional wellness heritage and science-led nutraceutical innovation. Hovid's strategic assets include established manufacturing and quality systems, product development competencies, and a distribution network that supports both domestic market coverage and international sales, with exports and product registrations across multiple geographies. The company's commercial reach includes pharmacies, clinics, hospitals, modern retail, and consumer channels, supported by marketing authorizations and regulatory compliance processes that are central to pharmaceutical operations (kelulusan pemasaran dan pematuhan kawal selia). Hovid's positioning emphasizes accessible and affordable healthcare solutions, product reliability, and continuous innovation in formulations, delivery systems, and value-added consumer health offerings. Geographically, its core base is Malaysia with a meaningful international footprint through group-led export activities and partnerships, enabling broad reach for selected product lines. The company's strategic focus includes portfolio expansion, brand strengthening, and supply reliability, supported by investments in product development and the capability to serve both medical and consumer segments through integrated pharmaceutical and consumer healthcare operations.